ETC
ABBV icon

Exchange Traded Concepts’s AbbVie ABBV Stock Holding History

Exchange Traded Concepts’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.6M Buy
105,544
+70,862
+204% +$15.2M 0.12% 164
2026
Q1 		$7.54M Sell
34,682
-69,733
-67% -$15.5M 0.05% 339
2025
Q4 		$23.9M Buy
104,415
+62,803
+151% +$14.3M 0.18% 109
2025
Q3 		$9.63M Sell
41,612
-34,825
-46% -$7.09M 0.08% 244
2025
Q2 		$14.2M Buy
76,437
+8,996
+13% +$1.67M 0.17% 145
2025
Q1 		$14.1M Sell
67,441
-7,120
-10% -$1.38M 0.24% 92
2024
Q4 		$13.2M Buy
74,561
+53,678
+257% +$9.87M 0.26% 80
2024
Q3 		$4.12M Sell
20,883
-96,682
-82% -$18M 0.1% 193
2024
Q2 		$20.2M Buy
117,565
+21,324
+22% +$3.53M 0.51% 48
2024
Q1 		$17.5M Sell
96,241
-62,635
-39% -$10.8M 0.45% 70
2023
Q4 		$24.6M Buy
158,876
+11,039
+7% +$1.61M 0.66% 37
2023
Q3 		$22M Buy
147,837
+22,346
+18% +$3.28M 0.62% 26
2023
Q2 		$16.9M Buy
125,491
+33,863
+37% +$4.97M 0.42% 69
2023
Q1 		$14.6M Sell
91,628
-33,935
-27% -$5.19M 0.4% 50
2022
Q4 		$20.3M Sell
125,563
-3,419
-3% -$524K 0.58% 13
2022
Q3 		$17.3M Buy
128,982
+4,066
+3% +$583K 0.57% 9
2022
Q2 		$19.1M Buy
124,916
+81,947
+191% +$12.5M 0.56% 23
2022
Q1 		$6.97M Sell
42,969
-55,128
-56% -$8.01M 0.14% 88
2021
Q4 		$13.3M Buy
98,097
+43,588
+80% +$5.15M 0.26% 54
2021
Q3 		$5.88M Sell
54,509
-85,895
-61% -$9.81M 0.15% 89
2021
Q2 		$15.8M Buy
140,404
+53,257
+61% +$6M 0.5% 30
2021
Q1 		$9.43M Sell
87,147
-666
-0.8% -$71.2K 0.35% 49
2020
Q4 		$9.41M Sell
87,813
-31,408
-26% -$3.02M 0.44% 30
2020
Q3 		$10.4M Buy
119,221
+75,950
+176% +$7.15M 0.59% 25
2020
Q2 		$4.25M Buy
43,271
+42,100
+3,595% +$3.71M 0.7% 29
2020
Q1 		$89K Buy
1,171
+1,075
+1,120% +$91.6K 0.05% 271
2019
Q4 		$8K Buy
+96
New +$7.97K ﹤0.01% 317

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Exchange Traded Concepts's ABBV Position: Q2 2026 in Review

Exchange Traded Concepts increased its AbbVie (ABBV) stake by 204% in Q2 2026, buying an estimated $15.2M and bringing the position to 105,544 shares worth $26.6M. The position accounts for 0.12% of the portfolio, ranked #164.

Exchange Traded Concepts first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Exchange Traded Concepts held 105,544 shares of AbbVie worth $26.6M as of Q2 2026.
  • Exchange Traded Concepts bought 70,862 AbbVie shares in Q2 2026, an estimated $15.2M.
  • AbbVie made up 0.12% of Exchange Traded Concepts's portfolio in Q2 2026, its #164 holding.
  • Exchange Traded Concepts first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.